transarterial chemoembolization
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
... to the Barcelona clinic liver cancer tumor staging, transarterial chemoembolization (TACE) is performed in patients with large or multinodal tumors where curative treat- ments are not feasible. However, ...
6
Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system
... cancer that predominantly occurs in liver cirrhosis patients, requires staging systems to design treatments. The barcelona clinic liver cancer staging system (BCLC) is the most commonly used HCC management guideline. For ...
10
Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis
... 15. Han KH, Kudo M, Ye SL, Choi JY, Poon RT, Seong J, Park JW, Ichida T, Chung JW, Chow P, Cheng AL: Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced ...
9
Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy
... Abstract: Transarterial chemoembolization (TACE) is the standard treatment for patients with Barcelona Clinic Liver Cancer-intermediate stage hepatocellular carcinoma ...
7
Long-term survival with transarterial chemoembolization and radioembolization in a patient with cancers of unknown primary
... including transarterial chemoembolization (TACE), hepatic arterial chemotherapy and tran- sarterial radioembolization (TARE) have been used to increase ...
5
Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma
... of transarterial chemoembolization (TACE) in patients with recurrent hepatocellular carcinoma (HCC) and that longer sorafenib duration was associated with additional survival ...
11
Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for the treatment of advanced intrahepatic cholangiocarcinoma
... Aim: To retrospectively evaluate the safety and efficacy of ultrasound-guided percutaneous microwave ablation (MWA) combined with simultaneous transarterial chemoembolization (TACE) in the treatment of ...
6
Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience
... that transarterial chemoembolization (TACE), the recom- mended treatment in patients with intermediate HCC, can also be safely and effectively performed in patients with advanced HCC defined by vascular ...
10
Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma
... Transarterial chemoembolization (TACE) is the current standard of care for hepatocellular carcinoma (HCC) in patients with multinodular disease, classified as intermediate stage (stage B) to Barcelona ...
12
Transarterial chemoembolization using iodized oil for unresectable hepatocellular carcinoma: perspective from multistep hepatocarcinogenesis
... Lp-TACE, transarterial chemoembolization using iodized oil; pHCC, poorly differentiated HCC; TACE, transarterial chemoembolization; wmHCC, well to moderately differentiated ...
6
Intravoxel Incoherent Motion Diffusion Weighted Imaging for the Therapeutic Response of Transarterial Chemoembolization for Hepatocellular Carcinoma
... Hepatocellular carcinoma (HCC) is one of the leading causes of cancer deaths worldwide and is a serious threat to human life and health. Because HCC often has an occlusive onset, patients are often in the advanced stages ...
11
Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization
... Background: The association of ABO blood group with prognosis of several malignancies has been established. However, its role in hepatocellular carcinoma (HCC) remains unclear. Patients and methods: In this study, we ...
8
Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis
... Background: Transarterial chemoembolization (TACE) is the recommended treatment for hepatocellular carcinoma (HCC) patients at Barcelona Clinic Liver Cancer (BCLC) B-stage, whereas sorafenib is an orally ...
13
Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective study
... settings, transarterial chemoembolization (TACE) is the current standard therapy for intermediate stage HCC (BCLC stage B) and an earlier study indicated combination of TACE with sorafenib as being more ...
9
The Prognostic Value of 18F-FDG PET/CT for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization (TACE)
... hepatocellular carcinoma (HCC). Baseline PET/CT has prognostic value in HCC patients, but there is litter knowledge of the PET/CT changes after treatment. We evaluated 27 HCC patients treated with transarterial ...
9
The Use of Dual Energy Computerized Tomography to Detect Residual Viable Hepatocellular Carcinoma after Transarterial Chemoembolization
... Transarterial chemoembolization (TACE) is an effective palliative treatment for unresectable tumor which interrupts arterial blood supply by chemoembolic agent and results in ischemic tumor ...
7
Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis
... Nowadays, Barcelona Clinic Liver Cancer (BCLC) stage is the sole system approved by the European Association for Study of the Liver (EASL) and American Association for the Study of Liver Disease (AASLD) guidelines for ...
19
Original Article Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma
... Abstract: Purpose: Transarterial chemoembolization (TACE) is an effective treatment for patients with unresectable hepatocellular carcinoma (HCC). However, acute kidney injury (AKI) is a severe complication ...
8
Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis
... Background: A number of cohort studies have compared the outcomes of transarterial chemoembolization (TACE) and hepatic resection (HR) in the treatment of hepatocellular car- cinoma (HCC). However, the ...
10
Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
... Objectives: To explore the efficacy and influencing factors of transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC) combined with portal vein tumor[r] ...
8